baber/WOPTO huggingface dataset:
Patent AU-2003220125-B2 (AU)
Title: Inhalation apparatus
Inventor: STEINER SOLOMON S
IPC: A61M15/06
Filed: 2003-03-07
Granted: 2006-06-15
Abstract: A cartridge (32) for use in an inhalation apparatus (20) comprising a mouthpiece (26) comprising a central bore (40), 
the cartridge comprising a head portion, a tail portion, at least one portion for receipt in a central bore of the inhalation apparatus, and a chamber (110) for storing an inhalable substance; 
wherein the cartridge is movable from a first position, where the chamber is closed to an ambient environment, to a second position, where a flow pathway from the ambient environment through the chamber has been opened, when the cartridge is engaged with the inhalation apparatus, and 
wherein the cartridge comprises structures (45,154) configured to engage with the inhalation apparatus and retain the second position once the second position has been reached.
Patent AU-2003300827-B2 (AU)
Title: Substituted piperazine compounds and their use as fatty acid oxidation inhibitors
Inventor: KOLTUN DMITRY
IPC: C07D277/64
Filed: 2003-12-05
Granted: 2009-08-13
Abstract: Disclosed are novel heterocyclic compounds having the structure which are useful for the treatment of various disease states, in particular cardiovascular diseases such as atrial and ventricular arrhythmias, intermittent claudication, Prinzmetal's (variant) angina, stable and unstable angina, exercise induced angina, congestive heart disease, and myocardial infarction. The compounds are also useful in the treatment of diabetes.
Patent AU-2004289920-B2 (AU)
Title: Pulp and paper made from Rhodophyta and manufacturing method thereof
Inventor: YOU HACK-CHURL
IPC: D21H11/12
Filed: 2004-11-12
Granted: 2007-11-29
Abstract: Disclosed is a method of manufacturing pulp and paper using Rhodophyta, including immersing Rhodophyta in an extraction solvent able to dissolve agar gel for a predetermined time period to dissolve the agar gel in the extraction solvent, reacting the dissolved agar gel with a reaction solvent to be converted into a fiber, curing the fiber using a curing agent, and pulping the cured fiber. The method of the current invention is advantageous because of lower manufacturing costs, due to eliminating the need to purchase wood. Further, the use of chemicals for lignin removal and bleaching drastically decreases, thus preventing environmental contamination. Furthermore, since a final product does not contain harmful chemicals, humans and the environment are not negatively affected.
Patent AU-2004296815-B2 (AU)
Title: Methods for the dietary management of irritable bowel syndrome and carbohydrate malabsorption
Inventor: LEFKOWITZ ANDREW R
IPC: A61K35/742
Filed: 2004-12-03
Granted: 2011-06-30
Abstract: The invention relates generally to digestive disorders, and in particular to methods for treating irritable bowel syndrome by increasing carbohydrate absorption by administering a composition containing bacterium.
Patent AU-2005233254-B2 (AU)
Title: Monoclonal antibodies with specificity for fetal erythroid cells
Inventor: STEFAN STACHELHAUS
IPC: G01N33/53
Filed: 2005-03-31
Granted: 2011-11-24
Abstract: The present invention concerns a monoclonal antibody and corresponding hybridoma cells and antigens suitable for isolating fetal cells from maternal blood. The monoclonal antibody reacts with a surface antigen present on fetal red blood cells including their nucleated precursor cells, but not with surface antigens on adult erythroid cell.
Patent AU-2005253081-B2 (AU)
Title: Biomarkers for peripheral artery disease
Inventor: COOKE JOHN P
IPC: G01N24/00
Filed: 2005-05-26
Granted: 2011-11-24
Abstract: This invention provides biomarkers whose concentrations in blood plasma are associated with the presence or absence of PAD in the patient from whom the plasma sample is taken. The invention also provides biomarkers for distinguishing between PAD patients who are long claudicators and PAD patients who are not. In addition, the invention provides methods for identifying additional biomarkers, methods for detecting the biomarkers in patients, and methods for identifying agents, including pharmaceutical agents, which interact with the biomarkers and are useful for preventing or treating PAD in patients.
Patent AU-2005294421-B2 (AU)
Title: Enhanced block acknowledgement
Inventor: NANDA SANJIV
IPC: H04W84/12
Filed: 2005-10-04
Granted: 2010-01-28
Abstract: Embodiments disclosed herein address the need in the art for enhanced block acknowledgement. In one embodiment, a receiver indicates a decoding delay for a maximum size aggregate frame in Block Ack negotiation, which may be used by a transmitter to determine to which Block Ack Request a Block Acknowledgement is responsive. In another embodiment, a Transmission Sequence Number (TSN) may be included in a Block Ack Request. The receiver includes the TSN in the corresponding Block Ack response. This allows the transmitter to determine which frames are 'in transit.' The TSN may be used to identify blocks. In another embodiment, a TSN may be associated with one or more transmitted frames. While, the TSN is not transmitted with the Block Ack Request, the transmitter may determine which TSN corresponds with a Block Ack response in accordance with acknowledgements contained therein. Combinations of these techniques may be deployed. Various other aspects are also presented.
Patent AU-2005316824-B2 (AU)
Title: Method of using extracts of epimedium species
Inventor: COHEN ISAAC
IPC: C12N5/00
Filed: 2005-12-09
Granted: 2012-05-31
Abstract: Extracts of various species of the family Berberidaceae have estrogenic properties. For example, aqueous and ethanolic extracts of species possess estrogenic properties in both ERα+ and ERβ+ cells. These estrogenic effect include estrogen response element (ERE) stimulation as well as tumor necrosis factor (TNF) repression. Methods are provided for treating climacteric symptoms, breast and/or uterine cancer, and osteoporosis.
Patent AU-2005326660-B2 (AU)
Title: Targeted delivery of Botulinum toxin for the treatment and prevention of trigeminal autonomic cephalgias, migraine and vascular conditions
Inventor: BLUMENFELD ANDREW M
IPC: A61K38/16
Filed: 2005-12-29
Granted: 2012-07-19
Abstract: Botulinum toxin, among other presynaptic neurotoxins is used for the treatment and prevention of migraine and other headaches associated with vascular disorders. Presynaptic neurotoxins are delivered focally, targeting the nerve endings of the trigeminal nerve, the occipital nerve and the intranasal terminals of the parasympathetic fibers originating in the Sphenopalatine ganglion. The administration preferably targets the extracranial nerve endings of the trigeminal nerve in the temporal area, the extracranial occipital nerve endings in the occipital area, and the intranasal terminals of the trigeminal nerve and parasympathetic fibers originating in the Sphenopalatine ganglion. The delivery is carried out by way of injection or topically.
Patent AU-2006201024-B2 (AU)
Title: Belt cleaner
Inventor: YOSHIZAKO KAGEYOSHI
IPC: B65G45/12
Filed: 2006-03-10
Granted: 2009-10-01
Abstract: A belt cleaner device is provided in which assembling of a frame and a cleaner head may be performed easily and quickly.  A belt cleaner device comprises a frame 3 and one or more cleaner heads 1. The frame 3 includes a support face (3a) on its upper surface, and a support hole (33) through the frame. The cleaner head (1) includes a contact face (14) on its undersurface, and an anchor (16) projecting downward from the contact face (14). The cleaner head (1) is supported so as not to be rotated about the running direction of the belt by contacting the contact face (14) and the support face (3a) with each other. The cleaner head (1) is fixed to the frame (3) by fixedly inserting the anchor (16) in the support hole (33).  The cleaner head (1) further provides a concave (21) in at least one of the front and rear walls (13) (15) to form a strike seat (22) at the bottom of the concave (21). The strike seat (22) is struck with a hammer or the like so that the anchor (16) is pressed and inserted in the support hole (33).
Patent AU-2006210673-B2 (AU)
Title: Optical fibre cleaving device
Inventor: VANDENBROECK JAN
IPC: G02B6/25
Filed: 2006-01-10
Granted: 2010-10-28
Abstract: A mechanism for cleaving and splicing optical fibres, comprising gripping members 41, 60 ( Figs. 7, 14 ) arranged to grip an optical fibre and to apply a pulling force to put the fibre under tension whilst the fibre is cleaved, and fibre cleaving means by which the fibre F is bent during cleaving by means of a rotatable double anvil 1, 2 ( Fig.13 ) widely separated from the gripping members. Preferably the gripping member(s) are arranged to eject a cleaved-off part of the fibre F into a receptacle 49 ( Fig. 7 ) once the fibre has been cleaved.
Patent AU-2006217545-B2 (AU)
Title: Smoking article with tobacco beads
Inventor: ZIMMERMANN STEPHEN
IPC: A24B15/24
Filed: 2006-02-23
Granted: 2012-04-05
Abstract: A component of a smoking article (100A) having tobacco beads. The tobacco beads can be located in a filter (104) and/ or a tobacco rod (102) . The filter (104) can be a multi-component filter, wherein an sorbent (preferably upstream) removes at least one constituent from mainstream tobacco smoke passing through the filter (104) and downstream tobacco beads compensates for taste lost to the sorbent . The tobacco beads optionally include flavorants in addition to tobacco particulates. The tobacco beads can be located within a cavity (112) in the filter (114) or within the tow. This component can comprise additional flavors, which are released into the mainstream smoke under ambient conditions . The tobacco beads optionally include binders such as microcrystalline cellulose or other cellulosic material, which can be formed into a paste with tobacco powder and optionally with additional flavors. The paste can be extruded and spheronized to form the tobacco beads .
Patent AU-2006242354-B2 (AU)
Title: Cell-surface decoration with active agents
Inventor: GROSSI FEDERICO V
IPC: A61K9/127
Filed: 2006-05-01
Granted: 2012-03-15
Abstract: A lipid vesicle comprising a functionalized lipid comprising a tether moiety having binding affinity for a ligand portion of an active agent and the active agent are provided. Methods of decorating endothelial cells, tissues, and organs with active agents utilizing the disclosed lipid vesicles are also provided.
Patent AU-2006298724-B2 (AU)
Title: Method of cell cultures and device for implementing it
Inventor: CASTILLO FERNANDEZ JOSE ANTONIO
IPC: C12M1/02
Filed: 2006-10-03
Granted: 2013-09-12
Abstract: Cell culture device (1) comprising a culture vessel (2) provided with a cover (19) in which there is a first zone (3) for transferring culture medium essentially free from cells internal to a second cell culture zone (5), a third (4) and a fourth zone (6) for transferring culture medium essentially free from cells. The third zone (4) is internal to the second zone (5) and external to the first zone (4) and the fourth zone (6) being a zone external to said second zone (5). All the zones are in medium communication. The device also comprises culture medium circulation means, allowing a circulation of the culture medium through the culture zone (5) from bottom to top.
Patent AU-2006334431-B2 (AU)
Title: Heat resistant coating
Inventor: ANDREWS ADRIAN FERGUSON
IPC: C09D183/04
Filed: 2006-12-20
Granted: 2012-02-09
Abstract: The present invention relates to coating compositions comprising a polysiloxane, a alkyl titanate, talc and/or mica, aluminium flakes, and optionally an alkyl orthosilicate or a condensation product thereof. The invention also relates to steel substrates coated with these coating compositions.
Patent AU-2007202810-B2 (AU)
Title: Loading machine
Inventor: CARSON MARK ALAN
IPC: B66F9/06
Filed: 2007-06-18
Granted: 2012-06-07
Abstract: Title: Loading machine 5 A wheeled loading machine (10) includes a body (11) mounting a loading arm (25), a ground engaging structure including a front axle (18) which carries a front pair of ground engaging wheels (15) and a rear axle (19) which carries a rear pair of ground engaging wheels (16), the loading arm (25) being mounted at a position (22) towards a rear of the machine (10) for up and down 10 movement about a generally horizontal axis (A), and the loading arm (25) extending forwardly beside a cab (9) which is mounted at one side of the body (11), to an outermost end which is beyond a front of the body (11), and the loading arm (25) having at its outermost end a mounting (34) for a loading implement (32) and the arm (25) being extendible to vary the length of the 15 loading arm, and each axle (18, 19) being suspended from the body (11) by a respective suspension, each of the ground engaging wheels (15, 16) being drivable by an engine (13) of the machine (10) through a mechanical transmission, and the machine (10) including a braking system (5) for braking each wheel (15, 16), the braking system (5) including a brake control system 20 which provides a brake anti-locking function to resist any braked ground engaging wheel (15, 16) skidding relative to the ground as a result of becoming locked during braking when a low friction condition exists between the wheel (15, 16) and the ground. C' "(9 cy))
Patent AU-2007227660-B2 (AU)
Title: Foamed-wall container having a silvery appearance
Inventor: SEMERSKY FRANK E
IPC: G03G15/08
Filed: 2007-03-12
Granted: 2012-04-05
Abstract: A container comprises a micro cellular foamed polymer, and a non- reactive gas contained within the micro cellular foam cells, wherein the container has a silvery appearance. The process for making the container comprises injection molding a polymer preform having a non-reactive gas entrapped within the walls thereof, cooling the preform to a temperature below the polymer softening temperature, reheating the preform to a temperature above the polymer softening temperature, and blow molding the preform, to prepare a container comprising a micro cellular foamed polymer having a non- reactive gas contained within the micro cellular foam cells.
Patent AU-2007243780-B2 (AU)
Title: Pneumatically operable fastener-driving tool and seal mechanism assembly, and a method of operating the same
Inventor: JOHNSON MICHAEL P
IPC: B25C1/04
Filed: 2007-03-20
Granted: 2011-06-30
Abstract: A pneumatically operable fastener-driving tool and seal mechanism assembly, and a method of operating the same, comprises the use of a single, annular seal member, having a substantially V-shaped cross-sectional configuration, disposed within an annularly recessed portion of the fastener-driving tool piston in such a manner that the open region of the V-shaped annular seal member is disposed toward the relatively high-pressure upstream end portion of the fastener-driving tool cylinder, while, conversely, the closed region of the V-shaped annular seal member is disposed toward the relatively low-pressure downstream end portion of the pneumatic tool cylinder. Accordingly, the relatively high-pressure air acts upon the radially outwardly flared lip portion of the annular seal member during a power stroke, while relatively low-pressure air acts upon the radially outwardly flared lip portion of the annular seal member during a return stroke, whereby only a single V-shaped annular seal member is required to achieve proper sealing performance characteristics throughout an operative cycle of the fastener-driving tool.
Patent AU-2007280407-B2 (AU)
Title: Process for preparing amorphous lercanidipine hydrochloride
Inventor: MOTTA GIANNI
IPC: C07D211/90
Filed: 2007-08-01
Granted: 2012-09-27
Abstract: The invention provides a process for preparing substantially pure amorphous lercanidipine hydrochloride. The amorphous lercanidipine hydrochloride prepared as disclosed herein is substantially pure and has a greater aqueous solubility and faster onset of the antihypertensive effect when administered to a patient, compared to crystalline lercanidipine hydrochloride. In a particular embodiment, the invention provides a method of preparing amorphous lercanidipine hydrochloride comprising (a) dissolving lercanidipine in an organic solvent to form a first solution, (b) contacting such a first solution with water or with a second water and/or organic HCl solution, (c) optionally adding water and, (d) recovering the precipitated amorphous lercanidipine hydrochloride.
Patent AU-2007313818-B2 (AU)
Title: Inhibitors of histone deacetylase
Inventor: DAVID SMIL
IPC: A61K31/553
Filed: 2007-10-26
Granted: 2013-02-14
Abstract: This invention relates to compounds for the inhibition of histone deacetylase. More particularly, the invention provides for compounds of formula (I) wherein (B), Q, J, L and Z are as defined in the specification.
Patent AU-2007322223-B2 (AU)
Title: Delta-8 desaturases and their use in making polyunsaturated fatty acids
Inventor: ZHU QUINN QUN
IPC: A23L11/00
Filed: 2007-10-22
Granted: 2012-12-13
Abstract: Isolated nucleic acid fragments and recombinant constructs comprising such fragments encoding delta-8 desaturases along with a method of making long-chain polyunsaturated fatty acids (PUFAs) using these delta-8 desaturases in plants and oleaginous yeast.
Patent AU-2007353360-B2 (AU)
Title: System and method for optimizing control of PCA and PCEA system
Inventor: BOLLISH STEPHEN
IPC: G16H40/63
Filed: 2007-06-13
Granted: 2013-08-29
Abstract: In a patient controlled analgesia (PCA) system, physiological data is processed and alarms are provided by the controller of the physiological module sensing the data according to a first rule. The physiological data is also processed by a second, separate controller according to a second rule independent from the first controller. According to the second rule, the physiological data may be filtered, processed with physiological data and non-physiological data obtained from another source, such as a remote server, and the PCA delivery device controlled to prevent delivery of medication accordingly. The provided system of multiple processors and rules enables normal alarming by physiological sensor modules while the pausing or prevention of the PCA delivery is controlled by a separate controller. Through this means, not only are false pauses and alarms for PCA delivery reduced, but the normal alarms of the monitors are permitted to function normally.
Patent AU-2008201044-B2 (AU)
Title: Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers
Inventor: HUBERT RENE S
IPC: C07K14/47
Filed: 2008-03-05
Granted: 2011-07-28
Abstract: Novel genes designated and set forth in Figure 2 and their respective encoded proteins, and variants thereof, are described wherein a gene of the invention exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in the cancers such as those listed in Table 1. Consequently, of gene products of a gene of Figure 2 provide diagnostic, prognostic, prophylactic and/or therapeutic targets for cancer. A gene of Figure 2 or fragment thereof, its encoded protein, or variants thereof, or a fragment thereof, can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with a gene product of Figure 2 can be used in active or passive immunization.
Patent AU-2008220934-B2 (AU)
Title: A rat trap
Inventor: FRITZBOGER PREBEN
IPC: A01M27/00
Filed: 2008-02-06
Granted: 2013-05-30
Abstract: A method and a console for the installation of powered equipment (1) in front of a sewer pipe opening (41) in a sewer shaft (50), the method comprising the steps of, selecting resilient tubular member (40) comprising a console adapted for mounting the powered equipment, the resilient tubular member having, in its unstressed state, an outer radius which slightly exceeds the inner radius of the sewer pipe opening, mounting. the powered equipment on the console positioning the resilient tubular member in front of the sewer pipe opening and compressing the resilient tubular member to obtain an outer radius being smaller than the inner radius of the sewer pipe opening, Inserting into the sewer pipe at least a part of the resilient tubular member, so that the console with the powered equipment extends inside the sewer shaft, releasing the compression of the resilient tubular member (40), so that it expands to engage with the inside of the sewer pipe opening (41).
Patent AU-2008227219-B2 (AU)
Title: Phosphorus recovery
Inventor: COHEN YARIV
IPC: C01B25/234
Filed: 2008-01-04
Granted: 2012-08-16
Abstract: Phosphorous ions are extracted (210) from solutions by adsorbing phosphorous ions in a scavenger and by releasing the phosphorous ions into an eluate during regeneration (230) of the scavenger. The regeneration (230) is performed by ammonia. Phosphate anions are precipitated (262) in form of tri-ammonium phosphate upon introduction (260) of excess amounts of ammonia. The ammonia remaining in solution after the precipitation of tri- ammonium phosphate is reused (266) for regenerating the scavenger.
Patent AU-2008251756-B2 (AU)
Title: Methods and compositions for heavy metal detoxification
Inventor: KONDA VEERA
IPC: C07D309/06
Filed: 2008-02-13
Granted: 2013-06-06
Abstract: Compositions and methods for enhancing heavy metal detoxification are described. The compositions and methods described provide enhanced activity of key detoxification systems including that the induction of phase II detoxification enzymes, such as glutathione s-transferases (GSTs), and NADPH quinone reductase (NQOl) activity.
Patent AU-2008304826-B2 (AU)
Title: Bubble column type hydrocarbon synthesis reactor, and hydrocarbon synthesis reaction system having the same
Inventor: YASUHIRO ONISHI
IPC: B01J8/22
Filed: 2008-09-26
Granted: 2011-09-08
Abstract: Disclosed is a bubble-column-type hydrocarbon synthesis reactor for synthesizing a hydrocarbon compound through the chemical reaction between a synthetic gas mainly composed of hydrogen and carbon monoxide with a slurry comprising a solid catalyst particle suspended in a liquid. The bubble-column-type hydrocarbon synthesis reactor comprises: a reactor main body for containing the slurry therein; a synthetic gas supply unit for supplying the synthetic gas to the slurry; and an introduction unit for introducing a cooling fluid having a temperature lower than that of the slurry into the interior of the reactor main body.
Patent AU-2008321488-B2 (AU)
Title: Immobilized biologically active entities having a high degree of biological activity
Inventor: PIETRZAK KRZYSZTOF R
IPC: A61L33/06
Filed: 2008-11-06
Granted: 2012-03-15
Abstract: The present invention relates to immobilized biologically active entities having heparin cofactor Il binding activity.
Patent AU-2008324959-B2 (AU)
Title: Player bonus choice
Inventor: IDDINGS CARA
IPC: G07F17/32
Filed: 2008-10-24
Granted: 2013-09-05
Abstract: A bonus management server may have a processor configured to transmit a plurality of bonuses to at least one gaming device for selection by a player and configured to and receive data from a plurality of servers and the plurality of gaming devices. A database may communicate with the processor to store data received from the gaming devices and servers, the database having a memory to store the plurality of bonuses, each of the plurality of bonuses associated with at least one qualifying bonus criteria, a player database to store player data received from the plurality of gaming devices and the plurality of servers, a data analyzer configured to determine whether the player is eligible to play for each of the plurality of bonuses, and an association table to associate a player with at least two of the plurality of bonuses.